Skip to main content
Top
Published in: Immunologic Research 4/2018

01-08-2018 | Original Article

Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy

Authors: Mohsen Saleh ElAlfy, Amira Abdel Moneam Adly, Fatma Soliman ElSayed Ebeid, Deena Samir Eissa, Eman Abdel Rahman Ismail, Yasser Hassan Mohammed, Manar Elsayed Ahmed, Aya Sayed Saad

Published in: Immunologic Research | Issue 4/2018

Login to get access

Abstract

Sickle cell disease (SCD) is associated with alterations in immune phenotypes. CD4+CD28null T lymphocytes have pro-inflammatory functions and are linked to vascular diseases. To assess the percentage of CD4+CD28null T lymphocytes, natural killer cells (NK), and IFN-gamma levels, we compared 40 children and adolescents with SCD with 40 healthy controls and evaluated their relation to disease severity and response to therapy. Patients with SCD steady state were studied, focusing on history of frequent vaso-occlusive crisis, hydroxyurea therapy, and IFN-gamma levels. Analysis of CD4+CD28null T lymphocytes and NK cells was done by flow cytometry. Liver and cardiac iron overload were assessed. CD4+CD28null T lymphocytes, NK cells, and IFN-gamma levels were significantly higher in patients than controls. Patients with history of frequent vaso-occlusive crisis and those with vascular complications had higher percentage of CD4+CD28null T lymphocytes and IFN-gamma while levels were significantly lower among hydroxyurea-treated patients. CD4+CD28null T lymphocytes were positively correlated to transfusional iron input while these cells and IFN-gamma were negatively correlated to cardiac T2* and duration of hydroxyurea therapy. NK cells were correlated to HbS and indirect bilirubin. Increased expression of CD4+CD28null T lymphocytes highlights their role in immune dysfunction and pathophysiology of SCD complications.
Literature
1.
go back to reference Belcher JD, Chunsheng Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 2014;123:377–90.CrossRefPubMedPubMedCentral Belcher JD, Chunsheng Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI. Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood. 2014;123:377–90.CrossRefPubMedPubMedCentral
2.
go back to reference Holtzclaw JD, Jack D, Aguayo SM, Eckman JR, Roman J, Hsu LL. Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice. Am J Respir Crit Care Med. 2004;169:687–95.CrossRefPubMed Holtzclaw JD, Jack D, Aguayo SM, Eckman JR, Roman J, Hsu LL. Enhanced pulmonary and systemic response to endotoxin in transgenic sickle mice. Am J Respir Crit Care Med. 2004;169:687–95.CrossRefPubMed
3.
go back to reference Nickel RS, Osunkwo I, Garrett A, Robertson J, Archer DR, Promislow DE, et al. Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy. Br J Haematol. 2015;169:574–83.CrossRefPubMedPubMedCentral Nickel RS, Osunkwo I, Garrett A, Robertson J, Archer DR, Promislow DE, et al. Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy. Br J Haematol. 2015;169:574–83.CrossRefPubMedPubMedCentral
6.
go back to reference Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med. 2004;10:119–24.CrossRefPubMed Vallejo AN, Weyand CM, Goronzy JJ. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med. 2004;10:119–24.CrossRefPubMed
7.
go back to reference Ingrid ED, Ernesto TA, Christina B, Juan CK. CD4+CD28null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res. 2009;81:11–9.CrossRef Ingrid ED, Ernesto TA, Christina B, Juan CK. CD4+CD28null T cells in coronary artery disease: when helpers become killers. Cardiovasc Res. 2009;81:11–9.CrossRef
9.
go back to reference Dumitriu IE, Baruah P, Finlayson CJ, Loftus IM, Antunes RF, Lim P, et al. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Circ Res. 2012;110:857–69.CrossRefPubMed Dumitriu IE, Baruah P, Finlayson CJ, Loftus IM, Antunes RF, Lim P, et al. High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome. Circ Res. 2012;110:857–69.CrossRefPubMed
10.
go back to reference Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331:44–9.CrossRefPubMedPubMedCentral Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, et al. Innate or adaptive immunity? The example of natural killer cells. Science. 2011;331:44–9.CrossRefPubMedPubMedCentral
11.
go back to reference Borrego F, Masilamani M, Marusina AI, Tang X, Coligan JE. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol Res. 2006;35:263–78.CrossRefPubMed Borrego F, Masilamani M, Marusina AI, Tang X, Coligan JE. The CD94/NKG2 family of receptors: from molecules and cells to clinical relevance. Immunol Res. 2006;35:263–78.CrossRefPubMed
12.
go back to reference Kirwan SE, Burshtyn DN. Regulation of natural killer cell activity. Curr Opin Immunol. 2007;19:46–54.CrossRefPubMed Kirwan SE, Burshtyn DN. Regulation of natural killer cell activity. Curr Opin Immunol. 2007;19:46–54.CrossRefPubMed
14.
go back to reference Damodar T, Kuruvilla TS, Kithan L. Natural killer cells: now and future. Experiment. 2014;25:1717–25. Damodar T, Kuruvilla TS, Kithan L. Natural killer cells: now and future. Experiment. 2014;25:1717–25.
15.
go back to reference Giubilato S, Liuzzo G, Brugaletta S, Pitocco D, Graziani F, Smaldone C, et al. Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J. 2011;32:1214–26.CrossRefPubMed Giubilato S, Liuzzo G, Brugaletta S, Pitocco D, Graziani F, Smaldone C, et al. Expansion of CD4+CD28null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur Heart J. 2011;32:1214–26.CrossRefPubMed
16.
go back to reference El-Samahy MH, Tantawy AA, Adly AA, Habeeb NM, Ismail EA, Hamed GM, et al. Expression of CD4+ CD28null T lymphocytes in children and adolescents with type 1 diabetes mellitus: relation to microvascular complications, aortic elastic properties, and carotid intima media thickness. Pediatr Diabetes. 2017;18:785–93.CrossRefPubMed El-Samahy MH, Tantawy AA, Adly AA, Habeeb NM, Ismail EA, Hamed GM, et al. Expression of CD4+ CD28null T lymphocytes in children and adolescents with type 1 diabetes mellitus: relation to microvascular complications, aortic elastic properties, and carotid intima media thickness. Pediatr Diabetes. 2017;18:785–93.CrossRefPubMed
17.
go back to reference Wethers DL. Sickle cell disease in childhood: part I. Laboratory diagnosis, pathophysiology and health maintenance. Am Fam Physician. 2000;62:1013–20.PubMed Wethers DL. Sickle cell disease in childhood: part I. Laboratory diagnosis, pathophysiology and health maintenance. Am Fam Physician. 2000;62:1013–20.PubMed
18.
go back to reference Kwiatkowski JL. Hemoglobinopathies. In: Lanzkowsky P, editor. Manual of pediatric hematology and oncology. 5th ed. London: Elsevier; 2011. p. 221. Kwiatkowski JL. Hemoglobinopathies. In: Lanzkowsky P, editor. Manual of pediatric hematology and oncology. 5th ed. London: Elsevier; 2011. p. 221.
19.
go back to reference van Beers EJ, Schaap MCL, Berkmans RJ, Nieuwland R, Sturk A, van Doormaal FF, et al. CURAMA study group. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009;94:1513–9.CrossRefPubMedPubMedCentral van Beers EJ, Schaap MCL, Berkmans RJ, Nieuwland R, Sturk A, van Doormaal FF, et al. CURAMA study group. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica. 2009;94:1513–9.CrossRefPubMedPubMedCentral
20.
go back to reference Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, et al. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr. 2012;160:286–90.CrossRefPubMed Darbari DS, Onyekwere O, Nouraie M, Minniti CP, Luchtman-Jones L, Rana S, et al. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr. 2012;160:286–90.CrossRefPubMed
21.
go back to reference Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood. 1998;92:3082–9.PubMed Bernini JC, Rogers ZR, Sandler ES, Reisch JS, Quinn CT, Buchanan GR. Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. Blood. 1998;92:3082–9.PubMed
22.
go back to reference Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics. 2008;121:777–82.CrossRefPubMed Pashankar FD, Carbonella J, Bazzy-Asaad A, Friedman A. Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics. 2008;121:777–82.CrossRefPubMed
23.
go back to reference Cappellini MD, Cohen A, Eleftheriou A, Eleftheriou A, Piga Aorter J, Taher A. Guidelines for the clinical management of Thalassaemia [Internet]. 2nd revised edition. Nicosia (CY): Thalassaemia International Federation; 2008. Chapter 2, Blood transfusion therapy in β-Thalassaemia major. Available from: https://www.ncbi.nlm.nih.gov/books/NBK173967/. Cappellini MD, Cohen A, Eleftheriou A, Eleftheriou A, Piga Aorter J, Taher A. Guidelines for the clinical management of Thalassaemia [Internet]. 2nd revised edition. Nicosia (CY): Thalassaemia International Federation; 2008. Chapter 2, Blood transfusion therapy in β-Thalassaemia major. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK173967/​.
25.
go back to reference Silvilairat S, Sittiwangkul R, Pongprot Y, Charoenkwan P, Phornphutkul C. Tissue doppler echocardiography reliably reflects severity of iron overload in pediatric patients with beta thalassemia. Eur J Echocardiogr. 2008;9:368–72.PubMed Silvilairat S, Sittiwangkul R, Pongprot Y, Charoenkwan P, Phornphutkul C. Tissue doppler echocardiography reliably reflects severity of iron overload in pediatric patients with beta thalassemia. Eur J Echocardiogr. 2008;9:368–72.PubMed
26.
go back to reference Morice WG. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. Am J Clin Pathol. 2007;127:881–6.CrossRefPubMed Morice WG. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders. Am J Clin Pathol. 2007;127:881–6.CrossRefPubMed
27.
go back to reference El-Rashedy FH, El-Hawy MA, Helwa MA, Abd-Allah SS. Study of CD4+, CD8+, and natural killer cells (CD16+, CD56+) in children with immune thrombocytopenic purpura. Hematol Oncol Stem Cell Ther. 2017;10:8–14.CrossRef El-Rashedy FH, El-Hawy MA, Helwa MA, Abd-Allah SS. Study of CD4+, CD8+, and natural killer cells (CD16+, CD56+) in children with immune thrombocytopenic purpura. Hematol Oncol Stem Cell Ther. 2017;10:8–14.CrossRef
28.
go back to reference Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113:4853–5.CrossRefPubMedPubMedCentral Hankins JS, McCarville MB, Loeffler RB, Smeltzer MP, Onciu M, Hoffer FA, et al. R2* magnetic resonance imaging of the liver in patients with iron overload. Blood. 2009;113:4853–5.CrossRefPubMedPubMedCentral
29.
30.
go back to reference Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, et al. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia. Haematologica. 2011;96:1605–12.CrossRefPubMedPubMedCentral Musallam KM, Cappellini MD, Wood JC, Motta I, Graziadei G, Tamim H, et al. Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia. Haematologica. 2011;96:1605–12.CrossRefPubMedPubMedCentral
31.
go back to reference Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123:1519–28.CrossRefPubMedPubMedCentral Carpenter JP, He T, Kirk P, Roughton M, Anderson LJ, de Noronha SV, et al. On T2* magnetic resonance and cardiac iron. Circulation. 2011;123:1519–28.CrossRefPubMedPubMedCentral
32.
go back to reference Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.CrossRefPubMed Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171–9.CrossRefPubMed
33.
go back to reference Merchant R, Joshi A, Ahmed J, Krishnan P, Jankharia B. Evaluation of cardiac iron load by cardiac magnetic resonance in thalassemia. Indian Pediatr. 2011;48:697–701.CrossRefPubMed Merchant R, Joshi A, Ahmed J, Krishnan P, Jankharia B. Evaluation of cardiac iron load by cardiac magnetic resonance in thalassemia. Indian Pediatr. 2011;48:697–701.CrossRefPubMed
35.
go back to reference Maly K, Schirmer M. The story of CD4+CD28− T cells revisited: solved or still ongoing? J Immunol Res. 2015;2015:348746.PubMedPubMedCentral Maly K, Schirmer M. The story of CD4+CD28− T cells revisited: solved or still ongoing? J Immunol Res. 2015;2015:348746.PubMedPubMedCentral
36.
go back to reference Mandal A, Viswanathan C. Natural killer cells: in health and disease. Hematol. 2015;8:47–55. Mandal A, Viswanathan C. Natural killer cells: in health and disease. Hematol. 2015;8:47–55.
37.
go back to reference West M, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: a cross-sectional analysis. J Clin Epidemiol. 1992;45:893–909.CrossRefPubMed West M, Wethers D, Smith J, Steinberg M. Laboratory profile of sickle cell disease: a cross-sectional analysis. J Clin Epidemiol. 1992;45:893–909.CrossRefPubMed
38.
go back to reference Lard LR, Mul FP, de Haas M, Roos D, Duits AJ. Neutrophil activation in sickle cell disease. J Leukoc Biol. 1999;66:411–5.CrossRefPubMed Lard LR, Mul FP, de Haas M, Roos D, Duits AJ. Neutrophil activation in sickle cell disease. J Leukoc Biol. 1999;66:411–5.CrossRefPubMed
39.
go back to reference Wallace KL, Marshall MA, Ramos SI, Lannigan JA, Field JJ, Strieter RM, et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood. 2009;114:667–76.CrossRefPubMedPubMedCentral Wallace KL, Marshall MA, Ramos SI, Lannigan JA, Field JJ, Strieter RM, et al. NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. Blood. 2009;114:667–76.CrossRefPubMedPubMedCentral
40.
go back to reference Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R, et al. P-Selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler Thromb Vasc Biol. 2010;30:2392–9.CrossRefPubMedPubMedCentral Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R, et al. P-Selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler Thromb Vasc Biol. 2010;30:2392–9.CrossRefPubMedPubMedCentral
41.
go back to reference Omoti CE. Haematological values in sickle cell anaemia in steady state and during vaso-occlusive crises in Benin City. Niger Ann Afr Med. 2005;4:62–7. Omoti CE. Haematological values in sickle cell anaemia in steady state and during vaso-occlusive crises in Benin City. Niger Ann Afr Med. 2005;4:62–7.
42.
go back to reference Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundade O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5:396–402.CrossRefPubMedPubMedCentral Akinbami A, Dosunmu A, Adediran A, Oshinaike O, Adebola P, Arogundade O. Haematological values in homozygous sickle cell disease in steady state and haemoglobin phenotypes AA controls in Lagos, Nigeria. BMC Res Notes. 2012;5:396–402.CrossRefPubMedPubMedCentral
43.
go back to reference Koffi KG, Sawadogo D, Meite M, Nanho DC, Tanoh ES, Attia AK, et al. Reduced levels of T-cell subsets CD4+ and CD8+ in homozygous sickle cell anaemia patients with splenic defects. Hematol J. 2003;4:363–5.CrossRefPubMed Koffi KG, Sawadogo D, Meite M, Nanho DC, Tanoh ES, Attia AK, et al. Reduced levels of T-cell subsets CD4+ and CD8+ in homozygous sickle cell anaemia patients with splenic defects. Hematol J. 2003;4:363–5.CrossRefPubMed
45.
go back to reference Musa BO, Onyemelukwe GC, Hambolu JO, Mamman AI, Isa AH. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis. Clin Vaccine Immunol. 2010;17(4):602–8.CrossRefPubMedPubMedCentral Musa BO, Onyemelukwe GC, Hambolu JO, Mamman AI, Isa AH. Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis. Clin Vaccine Immunol. 2010;17(4):602–8.CrossRefPubMedPubMedCentral
46.
go back to reference Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol. 2002;9:101–6.CrossRefPubMed Frenette PS. Sickle cell vaso-occlusion: multistep and multicellular paradigm. Curr Opin Hematol. 2002;9:101–6.CrossRefPubMed
47.
go back to reference Pitanga T, Vilas-Boas W, Cerqueira B, Seixas M, Barbosa C, Adorno E, et al. Cytokine profiles in sickle cell anemia: pathways to be unraveled. Adv Biosci Biotechnol. 2013;4:6–12.CrossRef Pitanga T, Vilas-Boas W, Cerqueira B, Seixas M, Barbosa C, Adorno E, et al. Cytokine profiles in sickle cell anemia: pathways to be unraveled. Adv Biosci Biotechnol. 2013;4:6–12.CrossRef
48.
go back to reference Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol. 2011;12:1202–11.CrossRefPubMedPubMedCentral Brennan PJ, Tatituri RV, Brigl M, Kim EY, Tuli A, Sanderson JP, et al. Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signals. Nat Immunol. 2011;12:1202–11.CrossRefPubMedPubMedCentral
49.
go back to reference Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med. 2003;198:1069–76.CrossRefPubMedPubMedCentral Stetson DB, Mohrs M, Reinhardt RL, Baron JL, Wang ZE, Gapin L, et al. Constitutive cytokine mRNAs mark natural killer (NK) and NK T cells poised for rapid effector function. J Exp Med. 2003;198:1069–76.CrossRefPubMedPubMedCentral
50.
go back to reference Field JJ, Lin G, Okam MM, Majerus E, Keefer J, Onyekwere O, et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013;121:3329–34.CrossRefPubMedPubMedCentral Field JJ, Lin G, Okam MM, Majerus E, Keefer J, Onyekwere O, et al. Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. Blood. 2013;121:3329–34.CrossRefPubMedPubMedCentral
51.
go back to reference Kaaba SA, Al Fazaa L. F cells, fetal hemoglobin levels, lymphocyte subsets, and frequency of crises in sickle-cell disease in Kuwait. Ann Hematol. 2000;79:291–5.CrossRefPubMed Kaaba SA, Al Fazaa L. F cells, fetal hemoglobin levels, lymphocyte subsets, and frequency of crises in sickle-cell disease in Kuwait. Ann Hematol. 2000;79:291–5.CrossRefPubMed
52.
go back to reference Mosmann TR. Cytokine secretion patterns and the cross regulation of T cell subsets. Immunol Res. 1991;10:183–8.CrossRefPubMed Mosmann TR. Cytokine secretion patterns and the cross regulation of T cell subsets. Immunol Res. 1991;10:183–8.CrossRefPubMed
53.
go back to reference Van Parijs L, Abbas AK. Homeostasis and self tolerance in the immune system: turning lymphocytes off. Science. 1998;280:243–8.CrossRefPubMed Van Parijs L, Abbas AK. Homeostasis and self tolerance in the immune system: turning lymphocytes off. Science. 1998;280:243–8.CrossRefPubMed
54.
go back to reference Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332:1317–22.CrossRefPubMed Charache S, Terrin ML, Moore RD, Dover GJ, Barton FB, Eckert SV, et al. Effect of hydroxyurea on frequency of painful crises in sickle cell anemia. N Engl J Med. 1995;332:1317–22.CrossRefPubMed
55.
go back to reference Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377:1663–72.CrossRefPubMedPubMedCentral Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377:1663–72.CrossRefPubMedPubMedCentral
56.
go back to reference Goncalves MS, Queiroz IL, Cardoso SA, Zanetti A, Strapazoni AC, Adorno E, et al. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Braz J Med Biol Res. 2001;34:1309–13.CrossRefPubMed Goncalves MS, Queiroz IL, Cardoso SA, Zanetti A, Strapazoni AC, Adorno E, et al. Interleukin 8 as a vaso-occlusive marker in Brazilian patients with sickle cell disease. Braz J Med Biol Res. 2001;34:1309–13.CrossRefPubMed
57.
go back to reference Wun T. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematology. 2001;5:403–12.CrossRefPubMed Wun T. The role of inflammation and leukocytes in the pathogenesis of sickle cell disease; haemoglobinopathy. Hematology. 2001;5:403–12.CrossRefPubMed
58.
go back to reference Wallace KL, Linden J. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood. 2010;116:5010–20.CrossRefPubMedPubMedCentral Wallace KL, Linden J. Adenosine A2A receptors induced on iNKT and NK cells reduce pulmonary inflammation and injury in mice with sickle cell disease. Blood. 2010;116:5010–20.CrossRefPubMedPubMedCentral
Metadata
Title
Immunological role of CD4+CD28null T lymphocytes, natural killer cells, and interferon-gamma in pediatric patients with sickle cell disease: relation to disease severity and response to therapy
Authors
Mohsen Saleh ElAlfy
Amira Abdel Moneam Adly
Fatma Soliman ElSayed Ebeid
Deena Samir Eissa
Eman Abdel Rahman Ismail
Yasser Hassan Mohammed
Manar Elsayed Ahmed
Aya Sayed Saad
Publication date
01-08-2018
Publisher
Springer US
Published in
Immunologic Research / Issue 4/2018
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI
https://doi.org/10.1007/s12026-018-9010-y

Other articles of this Issue 4/2018

Immunologic Research 4/2018 Go to the issue